Question 3 of 6 Intermediate Concept
How does epitope density affect apparent avidity?
Short answer
High local epitope density can enable simultaneous or sequential bivalent binding, slowing dissociation. Sparse or poorly spaced epitopes may prevent that avidity gain.
Why
Monovalent binding is influenced by intrinsic kinetic rates, while multivalent engagement adds geometric opportunities for rebinding. On a dense antigen surface, an IgG may retain one arm while the other reattaches, producing a slow apparent off-rate. On a sparse target, geometry may force predominantly single-arm binding.
Design a controlled density series using comparable cells or engineered surfaces and keep the antibody format, antigen presentation and incubation time fixed. Compare intact IgG with Fab fragments to separate valency from changes in epitope accessibility. Watch for mass-transport effects in SPR or biosensor assays, which can imitate slower kinetics.
For example, an engineered high-expression cell line can overestimate binding strength relevant to a low-expression tumor.
Common mistakes
- Assuming high antigen density automatically improves clinical efficacy or intrinsic Fab affinity
The interviewer might ask next
Why might an antibody rank differently on high- and low-antigen-density cells?